跳至主要内容
临床试验/ISRCTN05585501
ISRCTN05585501
已完成
未知

Prevention of foot ulcer recurrence in diabetes patients using plantar pressure biofeedback: a randomised controlled trial

Manchester Metropolitan University (UK)0 个研究点目标入组 58 人2013年10月4日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Topic: Diabetes Research Network
发起方
Manchester Metropolitan University (UK)
入组人数
58
状态
已完成
最后更新
5年前

概览

简要总结

2018 results presented at the 54th EASD Annual Meeting of the European Association for the Study of Diabetes in https://link.springer.com/content/pdf/10.1007%2Fs00125-018-4693-0.pdf [abstract 7] (added 24/06/2019) 2019 results in https://pubmed.ncbi.nlm.nih.gov/33323253/ (added 20/04/2021)

注册库
who.int
开始日期
2013年10月4日
结束日期
2017年10月31日
最后更新
5年前
研究类型
Interventional
性别
All

研究者

发起方
Manchester Metropolitan University (UK)

入排标准

入选标准

  • 1\. Diagnosed with Type 1 or 2 diabetes
  • 2\. A history of previous ulceration on the weight\-bearing surface of the foot
  • 3\. Presence of neuropathy (defined by any loss of sensation)
  • 4\. Ability to walk independently for approx. 100 metres (i.e., without use of wheelchair, walking stick or personal assistance)
  • 5\. Aged \>18 years
  • 6\. Able to understand all of the study requirements and have a life expectancy greater than the study duration
  • Target Gender: Male \& Female

排除标准

  • 1\. Active foot ulcer
  • 2\. In\-shoe orthotics consisting of non\-compressible materials
  • 3\. Presence of severe ischaemia for either foot defined by complete absence of foot pulses and ankle\-brachial pressure index \<0\.6
  • 4\. Lower limb amputation affecting the ability to walk approx. 100 metres
  • 5\. Dementia, uncorrected visual or psychological impairment
  • 6\. Psychiatric illnesses or social situations that would limit compliance with the study
  • 7\. Inner ear pathology, or other serious underlying balance dysfunction
  • 8\. Significant cardiopulmonary or other systemic disease limiting the patient's ability to walk approx. 100 metres unaided
  • 9\. Current participation in another clinical investigation of a medical device or a drug, or participation in such a study within 30 days prior to study enrolment
  • 10\. Body Mass Index (BMI) \>40

结局指标

主要结局

未指定

相似试验